![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 15, 9255-9260, April 10, 1998
From the Interleukin-9 (IL-9) is a cytokine with
pleiotropic effects on mast cell and T cell lines. It exerts its
effects through the IL-9R complex consisting of IL-9R
Heteromerization of the
c Chain with the
Interleukin-9 Receptor
Subunit Leads to STAT Activation and
Prevention of Apoptosis
§,
Institute for Biochemistry, Free University
Berlin, 14195 Berlin, Germany and § Gladstone Institute of
Virology and Immunology, University of California San Francisco,
San Francisco, California 94141-9100
and the common
c subunit. Here we report functional evidence for
receptor heteromerization for efficient signal transduction, and we
define minimal requirements in the two receptor subunits for IL-9R
function. Tyrosine 336 of the IL-9R
and the membrane-proximal
segment of
c are both crucial for signaling. The
activated IL-9R complex employs the Janus kinases JAK1 and JAK3 for
subsequent activation of the signal transducer and activator
transcription (STAT) factors STAT-1, STAT-3, and STAT-5. This process
is independent of Tyk2. We demonstrate further that the activated STAT
complexes consist of STAT-1 and STAT-5 homodimers and STAT-1-STAT-3
heterodimers. Finally, we show that IL-9R signaling in a T cell line
does not result in detectable mitogen-activated protein kinase
activation and leads to unsustained proliferation. Nonetheless, these T
cells are efficiently protected from dexamethasone-induced apoptosis.
These results further define the molecular architecture of the IL-9R
and its specific connections to various biologic responses.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. J. Lindemann, Z. Hu, M. Benczik, K. D. Liu, and S. L. Gaffen Differential Regulation of the IL-17 Receptor by {gamma}c Cytokines: INHIBITORY SIGNALING BY THE PHOSPHATIDYLINOSITOL 3-KINASE PATHWAY J. Biol. Chem., May 16, 2008; 283(20): 14100 - 14108. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Melen, H Gullsten, M Zucchelli, A Lindstedt, F Nyberg, M Wickman, G Pershagen, and J Kere Sex specific protective effects of interleukin-9 receptor haplotypes on childhood wheezing and sensitisation J. Med. Genet., December 1, 2004; 41(12): e123 - e123. [Full Text] [PDF] |
||||
![]() |
A. S. Gounni, Q. Hamid, S. M. Rahman, J. Hoeck, J. Yang, and L. Shan IL-9-Mediated Induction of Eotaxin1/CCL11 in Human Airway Smooth Muscle Cells J. Immunol., August 15, 2004; 173(4): 2771 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ratthe and D. Girard Interleukin-15 enhances human neutrophil phagocytosis by a Syk-dependent mechanism: importance of the IL-15R{alpha} chain J. Leukoc. Biol., July 1, 2004; 76(1): 162 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsukawa, K. Takeda, S. Kudo, T. Maeda, M. Kagayama, and S. Akira Aberrant Inflammation and Lethality to Septic Peritonitis in Mice Lacking STAT3 in Macrophages and Neutrophils J. Immunol., December 1, 2003; 171(11): 6198 - 6205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baraldo, D. S. Faffe, P. E. Moore, T. Whitehead, M. McKenna, E. S. Silverman, R. A. Panettieri Jr., and S. A. Shore Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1093 - L1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lindemann, M. Benczik, and S. L. Gaffen Anti-apoptotic Signaling by the Interleukin-2 Receptor Reveals a Function for Cytoplasmic Tyrosine Residues within the Common gamma (gamma c) Receptor Subunit J. Biol. Chem., March 14, 2003; 278(12): 10239 - 10249. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Little, W. W. Cruikshank, and D. M. Center IL-9 Stimulates Release of Chemotactic Factors from Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2001; 25(3): 347 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Gounni, B. Gregory, E. Nutku, F. Aris, K. Latifa, E. Minshall, J. North, J. Tavernier, R. Levit, N. Nicolaides, et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils Blood, September 15, 2000; 96(6): 2163 - 2171. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Demoulin, C. Uyttenhove, D. Lejeune, A. Mui, B. Groner, and J.-C. Renauld STAT5 Activation Is Required for Interleukin-9-dependent Growth and Transformation of Lymphoid Cells Cancer Res., July 1, 2000; 60(14): 3971 - 3977. [Abstract] [Full Text] |
||||
![]() |
A. Stephanou, B. K. Brar, T. M. Scarabelli, A. K. Jonassen, D. M. Yellon, M. S. Marber, R. A. Knight, and D. S. Latchman Ischemia-induced STAT-1 Expression and Activation Play a Critical Role in Cardiomyocyte Apoptosis J. Biol. Chem., March 31, 2000; 275(14): 10002 - 10008. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Park, H. Kim, J. M. Suh, S. J. Park, O-Y. Kwon, Y. K. Kim, H. K. Ro, B. Y. Cho, J. Chung, and M. Shong Thyrotropin Induces SOCS-1 (Suppressor of Cytokine Signaling-1) and SOCS-3 in FRTL-5 Thyroid Cells Mol. Endocrinol., March 1, 2000; 14(3): 440 - 448. [Abstract] [Full Text] |
||||
![]() |
C. BASBAUM, H. LEMJABBAR, M. LONGPHRE, D. LI, E. GENSCH, and N. MCNAMARA Control of Mucin Transcription by Diverse Injury-induced Signaling Pathways Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S44 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Humphreys and L. Hennighausen Signal Transducer and Activator of Transcription 5a Influences Mammary Epithelial Cell Survival and Tumorigenesis Cell Growth Differ., October 1, 1999; 10(10): 685 - 694. [Abstract] [Full Text] |
||||
![]() |
J.-B. Demoulin, E. Van Roost, M. Stevens, B. Groner, and J.-C. Renauld Distinct Roles for STAT1, STAT3, and STAT5 in Differentiation Gene Induction and Apoptosis Inhibition by Interleukin-9 J. Biol. Chem., September 3, 1999; 274(36): 25855 - 25861. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Gaffen, S. Y. Lai, G. D. Longmore, K. D. Liu, and M. A. Goldsmith Genetic Evidence for an Additional Factor Required for Erythropoietin-Induced Signal Transduction Blood, July 1, 1999; 94(1): 74 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Watowich, K. D. Liu, X. Xie, S. Y. Lai, A. Mikami, G. D. Longmore, and M. A. Goldsmith Oligomerization and Scaffolding Functions of the Erythropoietin Receptor Cytoplasmic Tail J. Biol. Chem., February 26, 1999; 274(9): 5415 - 5421. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stephanou, T. M. Scarabelli, B. K. Brar, Y. Nakanishi, M. Matsumura, R. A. Knight, and D. S. Latchman Induction of Apoptosis and Fas Receptor/Fas Ligand Expression by Ischemia/Reperfusion in Cardiac Myocytes Requires Serine 727 of the STAT-1 Transcription Factor but Not Tyrosine 701 J. Biol. Chem., July 20, 2001; 276(30): 28340 - 28347. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |